1343nok
3,0 %
Date:2025-05-23Time:18:00:00Latest report:Q1-2025List:Oslo BorsTicker:ZLNA
Market Cap:272 mnokEnterprise Value:138 mnokNet Sales:- mnokEarnings:-206,7 mnokEmployees:0ISIN:NO0013524942

Ratios

10-year key figure history for Zelluna turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Zelluna with index and moving average MA50 and MA200.

Stockprice:13,43
MA50:16,07
MA200:20,60
Price/MA200:-34,8 %
RSI (14):43,1
Price/MA50:-16,4 %

Description

Ultimovacs is a Norwegian pharmaceutical company. The company's business focus is to develop immunotherapies for various cancer conditions. Research and development are based on a self-based technological platform, where the products are mainly further developed as vaccines. The largest presence is in Europe and North America. Ultimovacs was founded in 2011 and is headquartered in Oslo.

Pharmaceuticals